| Literature DB >> 23320029 |
Laura C Dale1, Carolyn C Gotay.
Abstract
Objective. Complementary and alternative medicine (CAM) use is prevalent. Concurrently, breast cancer is the most common cancer in women worldwide, with early detection techniques widely available. This paper examined the overlap between participation in allopathic breast cancer early detection activities and CAM use. Methods. A systematic review examined the association between breast screening behaviors and CAM use. Searches were conducted on the PubMed, Embase, CINAHL, and NCCAM databases and gray literature between 1990 and 2011. STROBE criteria were used to assess study quality. Results. Nine studies met the search criteria. Four focused on CAM use in women at high breast cancer risk and five on average risk women. CAM use in women ranged from 22% to 82% and was high regardless of breast cancer risk. Correlations between CAM use and breast cancer early detection were not strong or consistent but significant relationships that did emerge were positive. Conclusions. Populations surveyed, and measures used to assess CAM, breast cancer screening, and correlates, varied widely. Many women who obtained allopathic screening also sought out CAM. This provides a foundation for future interventions and research to build on women's motivation to enhance health and develop ways to increase the connections between CAM and allopathic care.Entities:
Year: 2012 PMID: 23320029 PMCID: PMC3536331 DOI: 10.1155/2012/506978
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of Studies.
| Studya (Year) | Study design | Sample size | Selected participant characteristics | Data collection methods and CAM assessment | Period of CAM use assessed | Proportion of cancer-free participants using CAM | Breast screening measuresb | Relevant findings | Correlates of more CAM use |
|---|---|---|---|---|---|---|---|---|---|
| DiGianni, (2003 and 2006), [ | Cross-sectional (2003) Prospective cohort (2006) | 104 without cancer history | >18 yrs, F; Enrolled in a breast/ovarian genetic testing clinic; USA | Mailed questionnaire 83% response rate at 1 year Y/N 8 CAMsc | Ever use |
|
|
|
|
|
| |||||||||
|
Downey, (2009), [ | Cross-sectional | 71,083 | 52–64 yrs, F; enrolled in two washington state insurance companies; USA | Insurance claims data 4 kinds of insurance-paid CAM | Past year | Approximately 22–26% used CAM (depending on year); average 8 visits/yr <1% used only CAM therapies | Mam (past 2 years) | Complementary CAM use more likely to have Mam (OR 1.044; | Younger age, higher disease burden, enrolled in fee-for-service products; over the 3 measurement years; areas with lower education, income, and percentage of minority residents |
|
| |||||||||
| Druss, (1999), [ | Cross-sectional | 10,675 overall (# answering breast screening items NRf ) | >18 yrs, M/F, age and sex-appropriate subset answered breast questions; national probability sample (medical expenditure panel survey); USA | Interview 77% response rate Y/N 13 CAMs that are practitioner-based | Past year | 8.3% of overall sample; NRf for women answering breast screening items | CBE Mam (past year) | More CBE in CAM users (58.7%–95% CI: 57%–60%) than non-users (69.7%–95% CI; 65%–74%) ( | Female, caucasian, higher education, and residing in the west (USA) (only reported for overall sample) |
|
| |||||||||
|
Field, (2009), [ | Cross-sectional | 892 | 62% 40 yrs+, F; enrolled in the high breast cancer risk cohort; Australia and New Zealand | Mailed questionnaire— 73% response rate Y/N 35 CAMs | Ever use |
| Mam (past 3 yrs) | No association | More education and physical activity, clinical anxiety, being a former smoker and lower perceived BC risk |
|
| |||||||||
| Gollsche-wski, (2005), [ | Cross-sectional | 886 | 48–67 yrs, F; 61%, <55 yrs; random sample south-east Queensland, Australia | Mailed questionnaire— 59% response rate Y/N questions on herbal, phytoestrogen, nutrition and supplement CAMs | Ever use | 82% 67% used nutritional approaches, 56% used phytoestrogens, 41% used herbal therapies | CBE, BSE (past 2 yrs) | More BSE in herbal therapy users (OR 1.69, 95% CI 1.34–2.52; | Younger, higher education, middle income, lower smoking, previous hormone therapy, good physical/general health |
|
| |||||||||
| Gray, (2002), [ | Cross-sectional | 4404 | >40 yrs, M/F; stratified sample (by chronic conditions) from health plan; Minnesota, USA | Mailed questionnaire— 86% response rate Y/N 17 CAMs | Past year | 42% overall; 46% F | Mam (past yr) | CAM users significantly more likely to have had Mam (67% versus 62%) | Female, younger, higher education, single, employed, health limitations, improved health over past year. More exercise, vegetable intake, fast food consumption; less dietary fat and alcohol (only reported for overall sample) |
|
| |||||||||
| Mueller, (2008), [ | Cross-sectional | 135 without cancer history, knew BRCA1/2 status | 25–56 years of age, F; Enrolled in high genetic breast cancer risk clinic; USA | Telephone interview Y/N 13 CAMs | Past year | 78% overall; 69% if spiritual healing/prayer are excludede; average 2.3 CAM therapies; 34% ≥3 CAM therapies (overall sample) | Mam (annual) BSE (Monthly) | BSE and CAM use inversely related (OR 0.3, 95% CI 0.1–0.8; | Older, higher education, ovarian cancer worry |
|
| |||||||||
| Myers, (2008), [ | Cross-sectional | 2,198, varying risk based on family history | Average 63 yrs, F; family members of women enrolled in breast cancer family study; USA | Mailed questionnaire—70% response rate Y/N 8 CAMs | Ever use |
| BSE, CBE, Mam (ever) | In the univariate analysis, all 3 breast behaviors were associated with CAM use (OR 1.33, 95% CI 1.15–1.54; | Higher education, general health behaviors, optimism (multivariate analyses) |
|
| |||||||||
| Robinson, (2002), [ | Cross-sectional | 1,593 | >18 yrs, M/F, attendees at health fair USA | Questionnaire Y/N 8 CAMs, 13 herbs | Past 2 years | 68%; 63% used herbs/supplements | CBE Mam (Past 2 years) | No association | Younger, female, higher education (high school completion), lower levels of health insurance (only reported for overall sample) |
aStudies listed by first author.
bCBE: clinical breast examination; Mam: mammography; BSE: breast self-examination.
cY/N refers to dichotomous responses to use of each CAM treatment.
dThese data reflect the authors' abstract, data section, and conclusions; the table in the paper presents opposite numbers and is assumed to be a typesetting error.
eParticipants with cancer were included in this calculation because the authors state that overall patterns of the CAM therapies used didn't differ between cancer survivors and women without cancer and data were not presented separately for each group.
fNR: No response.
Complementary and Alternative Therapies as Reported by Selected Studies.
| Study | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | |
| Natural products and diet | |||||||||
| General vitamins/supplements | x | x | x | ||||||
| Chondroitin | x | ||||||||
| coQ10 | x | ||||||||
| Creatin | x | ||||||||
| Glucosamine | x | ||||||||
| Omega-3 folic acid | x | ||||||||
| High dose megavitamins | x | x | |||||||
| Selenium | x | ||||||||
| Vitamin E | x | ||||||||
| Other vitamins/supplements | x | ||||||||
| General herbal remedies | x | x | x | ||||||
| Bee Pollen | x | ||||||||
| Black Cohosh | x | ||||||||
| Dong Quai | x | ||||||||
| Echinacea | x | ||||||||
| Essiac | x | ||||||||
| Evening Primrose oil | x | ||||||||
| Flaxseed | x | ||||||||
| Ginko | x | ||||||||
| Ginseng | x | x | |||||||
| Green tea | x | ||||||||
| Kava Kava | x | ||||||||
| Milk thistle | x | ||||||||
| Red clover | x | ||||||||
| Saw Palmetto | x | x | |||||||
| Shark cartilage | x | x | |||||||
| Saint John's Wort | x | x | |||||||
| Soy | x | x | |||||||
| Valerian | x | ||||||||
| Wild Yam | x | ||||||||
| Other herbs | x | ||||||||
| Hormones | |||||||||
| Herbal Rx for menopause | x | ||||||||
| Phytoestrogen supplements | x | ||||||||
| Dietary phytoestrogens | x | ||||||||
| Melatonin | x | x | |||||||
| Tropical progesterone cream | x | ||||||||
| Special diet | x | x | |||||||
| Commercial weight loss programs | x | ||||||||
| Healthy eating | x | ||||||||
| Low fat diet | x | ||||||||
| Macrobiotic | x | ||||||||
| Soy rich diet | x | ||||||||
| Vegan | x | ||||||||
| Vegetarian | x | ||||||||
| Organic products | x | ||||||||
| Lifestyle diets | x | ||||||||
| Nutritional supplements | x | ||||||||
| Other diets | x | ||||||||
|
| |||||||||
| Manipulative and body-based practices | |||||||||
| Massage therapy | x | x | x | x | x | x | x | ||
| Reflexology | x | ||||||||
|
| |||||||||
| Mind and body medicine | |||||||||
| Acupuncture | x | x | x | x | x | x | x | ||
| Acupressure | x | ||||||||
| Hypnosis | x | x | x | x | |||||
| Imagery/visualization | x | x | x | x | |||||
| Meditation | x | x | x | x | x | ||||
| Relaxation techniques | x | x | x | x | |||||
| Tai chi/Chi gong | x | ||||||||
| Yoga | x | x | x | x | |||||
| Other mind body | x | ||||||||
|
| |||||||||
| Consultations | |||||||||
| Counselor/psychologist | x | ||||||||
| Chiropractic therapy | x | x | x | x | x | ||||
| Dietician | x | ||||||||
| Herbalist | x | ||||||||
| Homeopathy | x | x | x | x | x | ||||
| Lifestyle advice | x | ||||||||
| Naturopath | x | x | x | ||||||
| Nutritional advice | x | ||||||||
| Osteopathy | x | x | |||||||
|
| |||||||||
| Energy therapies | x | x | x | ||||||
| Reiki | x | ||||||||
| Biofeedback/Energy healing | x | x | x | x | x | ||||
|
| |||||||||
| Whole medical systems | |||||||||
| Traditional Chinese medicine | x | x | |||||||
| Ayurveda | x | ||||||||
| Folk remedies | x | ||||||||
| American Indian | x | ||||||||
|
| |||||||||
| Others | x | x | x | ||||||
| Exercise | x | ||||||||
| Prayer/spiritual practices | x | x | x | x | x | ||||
| Support groups | x | x | |||||||
| Other physical therapies | x | ||||||||
Studies: (1) DiGianni et al., (2003 and 2006), [14, 15]; (2) Field et al., (2009), [17]; (3) Mueller et al., (2008), [19]; (4) Myers et al., (2008), [20]; (5) Gollschewski et al., (2005), [18]; (6) Downey et al., (2009), [4]; (7) Robinson et al., (2002), [21]; (8) Druss and Rosenheck (1999), [16]; (9) Gray et al., (2002), [7].